51ÔÚÏß

Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
Return to PRWeb homepage
  • News
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • 51ÔÚÏß
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • ·¡²Ô±¹¾±°ù´Ç²Ô­³¾±ð²Ô³Ù

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All ·¡²Ô±¹¾±°ù´Ç²Ô­³¾±ð²Ô³Ù

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • °Õ±ð±ô±ð³¦´Ç³¾³¾Â­³Ü²Ô¾±³¦²¹³Ù¾±´Ç²Ô²õ

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All °Õ±ð±ô±ð³¦´Ç³¾³¾Â­³Ü²Ô¾±³¦²¹³Ù¾±´Ç²Ô²õ

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • 51ÔÚÏß PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • RSS
  • 51ÔÚÏß
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • ·¡²Ô±¹¾±°ù´Ç²Ô­³¾±ð²Ô³Ù
    • Heavy Industry & Manufacturing
    • °Õ±ð±ô±ð³¦´Ç³¾³¾Â­³Ü²Ô¾±³¦²¹³Ù¾±´Ç²Ô²õ
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • RSS
  • RSS
  • RSS

Norstella Launches Capsul, A Free Daily Intelligence Brief for the Pharma and Biotech Industry


News provided by

Norstella

Aug 27, 2026, 12:00 ET

Share this article

Share toX

Share this article

Share toX

A new weekday brief from the newsroom behind Pink Sheet, Scrip and In Vivo, distilling the day's most consequential drug development, regulatory and dealmaking news into a single, six-minute read

NEW YORK, Aug. 27, 2026 /PRNewswire-PRWeb/ -- Norstella, the leading global provider of AI-enabled pharma intelligence solutions, today announced the launch of , a free daily intelligence brief for the pharmaceutical and biotech industry. Each edition takes a single theme and adapts it into one flowing read that a busy professional can finish in minutes, leaving them with a clear picture of what moved, why it matters and what to watch next, without opening a single link.

Capsul comes from Norstella's News and Insights division, the reporters and editors behind the industry's most trusted names, including , and . It is built for the full span of the industry, from the business development director at an early-stage biotech to the 30-year veteran, on the premise that both deserve the same thing: coverage that is accurate to the specialist and a pleasure to read.

One edition lands each weekday morning, built around a single theme, moving across the week from clinical data to the regulators to the therapeutic areas that matter most. By Friday, a reader has seen the industry from every side that matters and never spent more than six minutes getting there. The editions carry a distinct voice, but the accuracy floor is non-negotiable, held to the editorial standards of Norstella News & Insights.

"Capsul is drawn from the same newsroom expertise customers have relied on for decades," said , President, Clinical and Strategic Intelligence, Norstella. "We are taking that rigor and making it a daily habit anyone in pharma or biotech can pick up in six minutes."

"Intelligent insights can be hard to come by," , Vice President of Norstella's News & Insights division, said. "We have a market-leading heritage of specialist news products delivering rich analysis for our enterprise customers. Capsul gives readers an opportunity to ingest a daily dose of these insights in and format."

Capsul is free to read during a limited launch period. The latest editions are available now at .

About Norstella

is the AI company for biopharma's highest-stakes decisions. A global life sciences company trusted by every Top 100 pharma company and industry experts the world over, Norstella unites market-leading brands — , , , , and — turning decision-grade data, insights and expertise into AI you can act on, from pipeline to patient. With the patient always at the center, Norstella is advancing the path to life-changing therapies for patients and providers. Follow us on .

For media inquiries, please contact:

[email protected]

Media Contact

Diffusion PR for Norstella, Norstella, 1 (888) 200-9288, [email protected],

SOURCE Norstella

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact 51ÔÚÏß

Products

My Services
  • All News Releases
51ÔÚÏß Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025  US Inc.